Drugs / Ringer acetate
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT03654001 | May 2019 → Oct 2024 | infectious disease with sepsis | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Completed | No outcome recorded |
| Phase 3 | NCT02336620 | Dec 2014 → Jan 2017 | infectious disease with sepsis | Ramathibodi Hospital | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05705115 | Mar 2024 → Oct 2025 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase not applicable2 trials · 1 missed | ||||||
| — | NCT05462847 | May 2021 → May 2022 | — | Kasr El Aini Hospital | Completed | No outcome recorded |
| — | NCT02961842 | Nov 2016 → Mar 2017 | — | Mansoura University | Completed | Missed primary |
| Comparator or background therapy5 trials | ||||||
| Phase 2 | NCT03092245 Comparator | Apr 2017 → Apr 2019 | infectious disease with sepsis | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 4 | NCT07322419 Background | Jan → Dec 2026 expected | — | Mansoura University | Recruiting | No outcome recorded |
| — | NCT04026685 Comparator | Jan 2020 → Feb 2021 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| — | NCT05914896 Comparator | Apr 2019 → Jun 2020 | acute kidney injury | Umeå University | Completed | No outcome recorded |
| — | NCT03252496 Comparator | Aug 2017 → Jul 2021 | preeclampsia | Mansoura University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ringer Acetate | “prime solution containing Ringer-Acetate 1000 ml + Mannitol 400 ml (60 g) + Sodium-Chloride 40 ml (160 mmol) and Heparin 2 ml (10 000 IU)” NCT05914896 ↗9“Ringer acetate 1000 mL will be administered over 10 minutes starting immediately after intrathecal injection” NCT07322419 ↗ “Ringer acetate 250 mL will be administered over 5 minutes starting immediately after intrathecal injection” NCT03252496 ↗ “Ringer acetate 500 mL will be rapidly infused immediately after intrathecal injection” NCT02961842 ↗ “Balanced crystalloid solutions (Ringer Lactate, Ringer Acetate, Crystalsol)” NCT03654001 ↗ |
| Modality | Other / unclassified | “balanced salt solution” NCT02336620 ↗ |
| Route | Intravenous | “Ringer acetate 10-20 ml/kg IV bolus” NCT02336620 ↗ |